Ur24Technology Receives Medicare Reimbursement for Revolutionary External Catheter System
Ur24 Technology, Inc. , a privately-held medical device company, has cleared a key hurdle to grow sales of its revolutionary external catheter system, winning approval for Medicare reimbursement for TrueClr products that actively empty a patient’s bladder.
- Ur24 Technology, Inc. , a privately-held medical device company, has cleared a key hurdle to grow sales of its revolutionary external catheter system, winning approval for Medicare reimbursement for TrueClr products that actively empty a patient’s bladder.
- Because TruClr products are reusable for up to a month, they provide significant savings over internal catheters, which must be replaced far more frequently.
- Ur24 Technology has a strategic partnership with Miami-based DemeTECH Corp. to manufacture and distribute TrueClr products in the US and internationally, using DemeTech’s network in 132 countries.
- Ur24Technology and DemeTECH will also jointly attend the 2023 Annual Meeting of the American Urological Association in Chicago, April 28-May 1.